指南与共识骨显像与常规 SPECT放射性药物与辐射防护

儿科核医学影像优化研究的开展与实施:IAEA协调研究项目的经验与建议

Developing and Implementing an Imaging Optimization Study in Pediatric Nuclear Medicine: Experience and Recommendations from an IAEA-Coordinated Research Project.
指南 / 共识 · J Nucl Med · 2020-08-28

国际原子能机构(IAEA)协调研究项目开发了5步影像优化方案,并在儿科核医学中测试。两站点以99mTc-DMSA肾皮质显像为例,站点1通过延长显像时间将给药活度降低30%并被后续31名儿童验证,站点2通过体模研究实现给药活度降低50%-70%且图像质量无损。该方案可帮助核医学诊所优化儿童显像实践。

要点

  • 5步优化方案:识别显像情境、采集基线给药活度与图像质量、与标准比较、确定干预、实施与评估。
  • 站点1:99mTc-DMSA显像延长至350秒可使给药活度降低30%,后续验证显示各年龄组平均相对差异30%-38%。
  • 站点2:体模研究表明延长显像时间可使给药活度较基线降低50%-70%且无图像质量损失。

核心结论

  • 剂量优化方法可成功应用于儿科核医学常见操作,99mTc-DMSA肾皮质显像的给药活度及辐射剂量显著降低。

研究设计与样本

  • IAEA协调研究项目开发并测试5步优化方案,两站点参与核医学优化项目,以99mTc-DMSA肾显像为例。
  • 站点1对29名儿童采集5帧动态数据模拟不同给药活度,站点2进行体模研究评估降低给药活度对图像噪声的影响。

主要发现

  • 站点1显示所有年龄组给药活度降低30%并延长显像至350秒可接受,后续31名儿童验证给药活度显著低于基线。
  • 站点1后续验证中0-5岁、5-10岁、10-15岁儿童的平均相对差异分别为30%、37%、38%。
  • 站点2体模研究发现延长显像时间可使给药活度较基线降低50%-70%而无图像质量损失。

关键数值与推荐

  • 站点1图像质量采用3点Likert量表主观评判,给药活度降低30%且显像时间350秒被判定为可接受。
  • 站点2体模研究确定延长显像时间下给药活度可较基线降低50%-70%且无图像质量损失。

临床怎么用

  • 核医学诊所可按5步优化方案识别显像情境、采集基线数据、对照标准、实施干预并评估,以优化儿科显像。
  • 对于99mTc-DMSA肾皮质显像,可考虑延长显像时间以降低给药活度,从而减少辐射剂量。

局限性

  • 原文未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The International Atomic Energy Agency instituted a coordinated research project on the evaluation and optimization of pediatric imaging, addressing the lack of consistency in this field. The purpose was to develop and test an optimization schema for the practices of pediatric radiology and nuclear medicine. Methods: A 5-step optimization schema was developed. Once a protocol optimization is identified, the steps are as follows: identification of the imaging situation; collection of administered-activity data and evaluation of the diagnostic image quality at baseline; comparison of baseline administered activity data with published standards or other benchmarks; identification of intervention, if necessary; and implementation of intervention and evaluation. Results: Within the coordinated research project, two sites considered optimization projects regarding nuclear medicine. In this work, renal imaging using 99mTc-dimercaptosuccinic acid (DMSA) projects are presented as examples. Site 1 acquired its standard 300-s static 99mTc-DMSA studies as 5-frame dynamic studies in 29 children. Frames were added to simulate different levels of administered activity. Image quality was subjectively judged on a 3-point Likert scale. A 30% reduction in administered activity with increased imaging duration (350 s) across all age groups was shown to be acceptable. This reduction was implemented and evaluated in 31 subsequent children, yielding administered activities significantly lower than baseline (mean relative differences of 30%, 37%, and 38% for children aged 0-5, 5-10, and 10-15 y, respectively). Site 2 performed a phantom study to determine the impact of lowering administered activity on image noise, finding that administered activities could be significantly lowered if longer imaging times were used. This led to a 50%-70% reduction from baseline with no loss in image quality. Conclusion: A dose optimization approach was applied successfully for several procedures commonly performed in pediatric nuclear medicine. Results are reported for renal cortical imaging using 99mTc-DMSA, leading to significant reductions in administered activity (and thus radiation dose). This optimization schema can be successfully implemented by nuclear medicine clinics seeking to improve their approach to imaging children.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Poli GL, Coca M, Torres L, et al. Developing and Implementing an Imaging Optimization Study in Pediatric Nuclear Medicine: Experience and Recommendations from an IAEA-Coordinated Research Project. J Nucl Med. 2020. PMID: 32859712. doi:10.2967/jnumed.120.244616

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。